Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 23, 2022
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
[ Mon, May 23rd 2022
] - WOPRAI
David Risinger Initiated (TBPH) at Buy and Held Target at $12 on, May 23rd, 2022
David Risinger of SVB Leerink, Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $12 on, May 23rd, 2022.
David has made no other calls on TBPH in the last 4 months.
There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Vikram Purohit of "Morgan Stanley" Maintained at Sell with Increased Target to $11 on, Wednesday, March 2nd, 2022
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Thursday, February 24th, 2022
